Sow P, Gueye P, Ba P, Diouf M, Diakhate , Ngom N, Sow P, Coly Y; International Conference on AIDS.
Int Conf AIDS. 2002 Jul 7-12; 14: abstract no. TuPeF5301.
Dakar, Senegal
BACKGROUND: Recently reported data suggests that indicators of clinical wasting may persist beyond the successful reduction of viral load and improvement in CD4 counts. This investigatio was conducted to determine the relationships between markers of desease progression and weight or body composition changes. Information about treatment with highly active antiretroviral therapies (HAART) were included in the evaluation. METHODS: An observational database compiled profiles of more than 150 out patients over a period of 3 months to one year. Data were collected on weight (wt), body composition (body mass index (BMI), body cell mass (BCM) and medication profile. RESULTS: The average percent increase in total weight was 16 lbs (11,2 %). The largest weight percent increase was 23% and the lowest was 2%. The average BCM percent increase was 10,2lbs (15,8%) and CDA count increased in average of 23%. CONCLUSIONS: The result showed the importance of the weight and body composition, it may be one of the main stool to evaluate the HIV evolution.
Publication Types:
Keywords:
- AIDS Vaccines
- Acquired Immunodeficiency Syndrome
- Anti-HIV Agents
- Antiretroviral Therapy, Highly Active
- Body Composition
- Body Mass Index
- Body Weight
- CD4 Lymphocyte Count
- Evaluation Studies
- HIV
- HIV Infections
- HIV Seropositivity
- Humans
- Nutritional Status
- Observation
- Primary Health Care
- Viral Load
- Weight Gain
- Weights and Measures
- methods
Other ID:
UI: 102250693
From Meeting Abstracts